Rebound effects of NCX3 pharmacological inhibition: A novel strategy to accelerate myelin formation in oligodendrocytes-Reference-Cited by-同舟云学术

Rebound effects of NCX3 pharmacological inhibition: A novel strategy to accelerate myelin formation in oligodendrocytes

Published:2021-11 Issue: Volume:143 Page:112111
ISSN:0753-3322
Container-title:Biomedicine & Pharmacotherapy
language:en
Short-container-title:Biomedicine & Pharmacotherapy

Author:

Cammarota Mariarosaria,de Rosa Valeria,Pannaccione Anna,Secondo Agnese,Tedeschi Valentina,Piccialli Ilaria,Fiorino Ferdinando,Severino Beatrice,Annunziato Lucio,Boscia Francesca

Funder

Fondazione Italiana Sclerosi Multipla

Ministero dell’Istruzione, dell’Università e della Ricerca

Publisher

Elsevier BV

Subject

Pharmacology,General Medicine

Reference57 articles.

1. Regulation of developing myelin sheath elongation by oligodendrocyte calcium transients in vivo;Krasnow;Nat. Neurosci.,2018

2. Ca2+ activity signatures of myelin sheath formation and growth in vivo;Baraban;Nat. Neurosci.,2018

3. Differential expression of the Na+-Ca2+ exchanger transcripts and proteins in rat brain regions;Papa;J. Comp. Neurol.,2003

4. Ionic transporter activity in astrocytes, microglia, and oligodendrocytes during brain ischemia;Annunziato;J. Cereb. Blood Flow Metab.,2013

5. New roles of NCX in glial cells: activation of microglia in ischemia and differentiation of oligodendrocytes;Boscia;Adv. Exp. Med. Biol.,2013

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Contribution of Oligodendrocytes, Microglia, and Astrocytes to Myelin Debris Uptake in an Explant Model of Inflammatory Demyelination in Rats;Cells;2023-09-03

2. Combined targeting of fatty acid amide hydrolase and melatonin receptors promotes neuroprotection and stimulates inflammation resolution in rats;British Journal of Pharmacology;2023-01-06

3. The Na+/Ca2+ Exchanger 3 Is Functionally Coupled With the NaV1.6 Voltage-Gated Channel and Promotes an Endoplasmic Reticulum Ca2+ Refilling in a Transgenic Model of Alzheimer’s Disease;Frontiers in Pharmacology;2021-12-08